Related Experiment Video
Updated: Apr 29, 2026
07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
8.3K
Syncope risk stratification tools vs clinical judgment: an individual patient data meta-analysis
Giorgio Costantino1, Giovanni Casazza2, Matthew Reed3
1Medicina fisiopatologica, Dipartimento di Medicina Interna, Osp. L. Sacco, Milano, Italy.
The American Journal of Medicine
|May 28, 2014
Summary
Syncope prediction tools lack sensitivity and specificity, performing no better than clinical judgment for serious outcomes. Current tools should not be strictly used in clinical practice for syncope management.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Decision-Making
Background:
- Syncope prediction tools aim to guide clinical decisions but face adoption challenges due to insufficient sensitivity and specificity.
- External validation and comparison with clinical judgment are crucial for assessing these tools' utility.
Purpose of the Study:
- To externally validate existing syncope prediction tools.
- To compare the performance of syncope prediction tools against clinical judgment.
Main Methods:
- An individual patient data meta-analysis approach was employed.
- Prospective studies of syncope patients in emergency departments were screened.
- Pooled sensitivities, specificities, and diagnostic odds ratios were calculated for prediction tools and clinical judgment.
Main Results:
- Six studies contributed data for 3681 patients.
- Three tools (OESIL, SFSR, EGSYS) were assessed.
- No prediction tool outperformed clinical judgment in identifying serious outcomes during emergency department stay or at 10 and 30 days post-syncope.
Conclusions:
- Despite using an individual patient data approach, significant variability persisted among studies.
- Current syncope prediction tools do not offer superior sensitivity, specificity, or prognostic yield compared to clinical judgment for short-term serious outcomes.
- Evidence suggests that current syncope prediction tools should not be rigidly applied in clinical practice.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
01:30Heart Failure IV: Classification and Diagnostic Evaluation
919
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
919
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
01:12Relative Risk
2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
01:30Acute Coronary Syndrome III: Diagnostic Studies
493
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
01:25Strategies for Assessing and Addressing Confounding
584
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
584